ArticleImmunity, inflammation and disease2023

Seroconversion after SARS-CoV-2 vaccination is protective against severe COVID-19 disease in heart transplant recipients.

Szilvia Kugler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.